These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7559139)

  • 1. Anti-androgen effects of the aromatase inhibitor, atamestane.
    Shao TC; Marcelli M; Kong A; Cunningham GR
    J Androl; 1995; 16(2):100-7. PubMed ID: 7559139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA.
    Martel C; Trudel C; Couet J; Labrie C; Bélanger A; Labrie F
    Mol Cell Endocrinol; 1993 Feb; 91(1-2):43-9. PubMed ID: 8472853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate.
    Rittmaster RS; Magor KE; Manning AP; Norman RW; Lazier CB
    Mol Endocrinol; 1991 Jul; 5(7):1023-9. PubMed ID: 1719382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism.
    Kelce WR; Lambright CR; Gray LE; Roberts KP
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):192-200. PubMed ID: 9007049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiandrogenic effects in short-term in vivo studies of the fungicide fenarimol.
    Vinggaard AM; Jacobsen H; Metzdorff SB; Andersen HR; Nellemann C
    Toxicology; 2005 Feb; 207(1):21-34. PubMed ID: 15590119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 4-MAPC, a 5 alpha-reductase inhibitor, and cyproterone acetate on regrowth of the rat ventral prostate.
    Shao TC; Kong A; Cunningham GR
    Prostate; 1994 Apr; 24(4):212-20. PubMed ID: 7511803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of androstenedione-induced prostate growth in intact beagle dogs by a combined treatment with the antiandrogen cyproterone acetate and the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione (1-methyl-ADD).
    Habenicht UF; el Etreby MF
    Prostate; 1989; 14(4):309-22. PubMed ID: 2473459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-MAPC, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight, DNA, and prostatein concentrations.
    Ghusn HF; Shao TC; Klima M; Cunningham GR
    J Androl; 1991; 12(5):315-22. PubMed ID: 1765567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate.
    Labrie C; Simard J; Zhao HF; Belanger A; Pelletier G; Labrie F
    Endocrinology; 1989 Jun; 124(6):2745-54. PubMed ID: 2524377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review.
    el Etreby MF
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):565-72. PubMed ID: 7682838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action and pure antiandrogenic properties of flutamide.
    Labrie F
    Cancer; 1993 Dec; 72(12 Suppl):3816-27. PubMed ID: 8252497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of an antiandrogen and a 5 alpha-reductase inhibitor: a further step towards total androgen blockade?
    Labrie C; Trudel C; Li S; Martel C; Couêt J; Labrie F
    Endocrinology; 1991 Jul; 129(1):566-8. PubMed ID: 2055205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
    Nishino Y; Schneider MR; Michna H; el Etreby MF
    J Steroid Biochem; 1989; 34(1-6):435-7. PubMed ID: 2533949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatein C3-mRNA: a sensitive marker of androgen-responsiveness in prostate explant cultures.
    Shao TC; Kong A; Young C; Chu WH; Tindall DJ; Cunningham GR
    Prostate; 1990; 17(1):41-55. PubMed ID: 2201006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of prostate gene expression and tissue weight changes as monitors of antiandrogen activity in GNRH-inhibited rats.
    Nellemann C; Lefevre PA; Ashby J
    Birth Defects Res B Dev Reprod Toxicol; 2003 Aug; 68(4):344-54. PubMed ID: 14666997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of finasteride on the rat ventral prostate.
    Shao TC; Kong A; Marafelia P; Cunningham GR
    J Androl; 1993; 14(2):79-86. PubMed ID: 8390428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estradiol on prostate epithelial cells in the castrated rat.
    Pelletier G
    J Histochem Cytochem; 2002 Nov; 50(11):1517-24. PubMed ID: 12417618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic luminal cell differentiation and prostatic steroid-binding protein (PBP) gene expression are differentially affected by neonatal castration.
    Janulis L; Nemeth JA; Yang T; Lang S; Lee C
    Prostate; 2000 May; 43(3):195-204. PubMed ID: 10797494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergic inhibitory effects of the aromatase inhibitor 1-methyl-androsta-1, 4-diene-3, 17-dione and the antiandrogen cyproterone acetate on androstenedione-induced hyperplastic effects in the prostates of castrated dogs.
    Habenicht UF; el Etreby MF
    Prostate; 1987; 11(2):133-43. PubMed ID: 2444953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.